180 Life Sciences Corp. fell 5.78% in premarket trading, with the company's shares dropping after announcing a $500 million stock offering. The company is focused on developing new technologies across multiple sectors, including the iGaming sector through its iGaming Technology Platform, and continues to evaluate monetization strategies for its biotechnology assets.
Comments
No comments yet